News

Researchers at the University of Liverpool have found that the weight loss drug, Tirzepatide is associated with significantly reduced risk of developing type 2 diabetes (T2D).

A view into how nanoscale building blocks can rearrange into different organized structures on command is now possible.

Researchers discovered that targeting the ERBB2 gene in mice with PTEN mutations significantly slowed endometrial cancer growth. This finding offers hope for alternative treatments beyond hysterectomy and aggressive therapies.

By encouraging AlphaFold2 to focus on "energetic frustration", researchers have found a new way to predict how proteins change shape.

A new technique may help reveal unknown benefits of existing drugs, according to a new study. The new approach, called decryptE, could help identify new applications for already approved drugs and take steps toward precision medicine.

Researchers found that depleting gut bacteria in newborns through antibiotics leads to lifelong allergies. This discovery opens doors to potential new treatments targeting allergies at their source.

A UC Davis Health study found that naloxone improves outcomes in opioid-associated out-of-hospital cardiac arrests (OHCA), leading to both increased return of spontaneous circulation and survival to hospital discharge.

Researchers discovered a hormone-like toxin in cone snail venom that mimics human somatostatin, regulating blood sugar and hormone levels with greater stability and specificity.

University of Vienna researchers developed MolCompass, a tool that identifies blind spots in machine learning models used for chemical risk assessment. The tool aims to increase transparency and confidence in computational models.

A study found that lecanemab effectively targets amyloid plaques in brain tissue of people with Down syndrome, who are prone to early Alzheimer's. While promising, the drug also binds to brain blood vessels, raising safety concerns.